Effect of cupping on pulmonary symptoms of COVID-19

Phase 3

Recruiting

• Conditions: COVID-19.; Probable COVID-19; U07.1

• Registration Number: IRCT20210515051296N1
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 55

Inclusion Criteria

Patients 18 to 65 years
Resident of Qazvin
Willingness to participate in the research project and complete the consent form
Presence of typical evidence on lung CT-Scan or positive specific RT-PCR test from oropharyngeal secretions
Presence of clinical criteria for hospitalization (fever above 38 ° C or severe cough or shortness of breath or respiratory rate greater than 24 per minute or oxygen saturation less than 93%)

Exclusion Criteria

Having a history of coagulation diseases, obesity, deep vein thrombosis
Have a history of vertebral fracture or disc herniation
Patients during pregnancy, lactation, and menstruation
Patients with heart failure
Patients with chronic renal failure
cancer patients
Patients with defective immune system or Patients receiving corticosteroids
Existence of open wound at the site of cupping

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Arterial blood oxygen saturation. Timepoint: At the beginning of the study (before the intervention) and the first to fourteenth days during cupping therapy. Method of measurement: Pulse oximetry.